Vancomycin resistant enterococci (VRE) are a major medical concern globally. Their significantly greater prevalence and the ability to transfer resistance to vancomycin from other bacteria made them an object of interest and intense research. The isolates of Enterococcus sp. were subjected to Ezeah et al.; JAMB, 16(3): 1-20, 2019; Article no.JAMB.48423 2 antibiotic susceptibility testing before curing. The three Enterococcus species exhibited different antibiotic resistance profile. Pre-curing antibiotic resistance of nosocomial isolates compared with community acquired isolates revealed that high percentage of the nosocomial isolates were resistant to antibiotics compared to community isolate. Post-curing antibiograms of the isolates showed different resistant and susceptibility pattern. Also, DNA plasmid pre-curing and post curing analysis of the isolates showed different resistance pattern. Six of the 15 representative isolates selected on the basis of their high pre-curing antibiotic resistance for plasmid analysis with 0.8% agarose electrophoresis were positive for plasmid DNA. Four (4) of the positive isolates (E. faecium, E. faecium, E. faecalis, and E. avium) had plasmid fragment of greater than 1000 bp while two (2) of them (E. faecalis and E. faecalis) had fragments of between 100 and 500 bp. The remaining nine (9) had no plasmid DNA. The study revealed the pathogenicity factors demonstrated with the enterococcal isolates.
INTRODUCTION
High level of intrinsic antibiotic resistance is one of the important features of the genus Enterococcus. Some of them are intrinsically resistant to some β-lactam-based antibiotics (some penicillins and virtually all cephalosporins) as well as to many aminoglycosides [1] . Between 1989 and 2009, strains of particularly virulent and vancomycin-resistant enterococci (vancomycinresistant Enterococcus or ERV) emerged in hospital-acquired nosocomial infections, particularly in the United States of America [2] .
Resistance to vancomycin occurs when a sensitive enterococcus acquires a plasmid that confers resistance to vancomycin.The new strain is called vancomycin resistant Enterococcus (VRE). Unrelated bacteria such as methicillin resistant Staphylococcus aureus (MRSA) can acquire vancomycin resistance from VRE to form new strains called VRSA. Furthermore, MRSA (VRE organisms) are usually resistant to more than one antibiotic [2] . VRE can be transmitted from person to person and are increasing problems in chronic hospitalized patients. The most prevalent enterococcus species in humans are Enterococcus faecalis and Enterococcus faecium; contributing to more than 90% of clinical isolates [3] . Other enterococcal species are: Enterococcus avium, Enterococcus gallinarum, Enterococcus casselflavus, Enterococcus durans, Enterococcus raffinosus and Enterococcus mundtii. The most vancomycin resistant strain is E. faecium [2] .
Enterococci's acquisition of vancomycin resistance has seriously affected these organisms' treatment and infection control. Six phenotypes of vancomycin resistance termed vanA, vanB, vanC, vanD, vanE and vanG have been described. The vanA, vanB phenotypes are clinically significant and mediated by 1-2 acquired transferable operons that consist of 7genes in 2 clusters termed VANA VANB operons. First reported in enterococcal strains were these gene clusters in 1988. VanA is carried on a plasmid-mediated Transposon Tn 1546 [4] .
However, DNA plasmid curing achieved by treatments with some reagents is most likely to promote the loss of resident plasmid DNA from a cell and to cause loss of resistance. Curing of plasmid is done to determine whether a plasmid encodes a trait or not. A trait is said to be plasmid-borne if plasmid encodes information about it. Curing of plasmid could be achieved using any of these: novobiocin, ethidium bromide (EtBr), acriflavin, acridine orange dye, plumbagin, sodium deodecyl sulphate (SDS) [5] .
Enterococci virulence is lower than organisms such as Staph. aureus [6] . Risk factors for mortality associated with enterococcal bacteraemia include disease severity, the age of the patient and the use of broad-spectrum antibiotics [7] . Some enterococcal strains produce gelatinase, a proteolytic enzyme with an extracellular zinc containing metalloproteinase [8] . Gelatinase can hydrolyse gelatin, collagen, fibrinogen, casein, haemoglobin and other bioactive peptides [9] . It is also responsible in oral infection for inflamed pulp and periapical lesions [8] . Gelatinase has played a major role in most pathogenic bacteria's pathogenicity. Due to its cytotoxic and tissue destructive potential and inhibitory effects on phagocytes, the enzyme was associated with disease progression [10] . The production and activity of gelatinase in enterococcal infections in clinical isolates are higher than that of healthy volunteers [11] .
Vancomycin -Dependent Enterococcus (VDE)
In 1993, the first documented strain of vancomycin-dependent enterococcus (VDE) was isolated from the urine of a 46-year-old woman at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania [12] . Twenty additional cases of VDE have been reported worldwide since this first isolate was reported, including both E. Fecalis and E. faecium strains. Even though the clinical significance of VDE remains unclear, a 1999 outbreak of VDE was reported in a bone marrow transplant unit at Johns Hopkins University [13] and shows its potential to become a pathogen of clinical significance.
Another mechanism of enterococci resistance to antibiotics is the formation of biofilm. Biofilm is a population of cells in a hydrated matrix of exopolymeric substances, proteins, polysaccharides and nucleic acids that are irreversibly attached to many biotic and abiotic surfaces [14] . Biofilm formation is a complex development process involving surface attachment and immobilization, cell-to-cell interaction, microcolony formation, confluent biofilm formation and the development of a threedimensional biofilm structure [15] . In a biofilm, bacteria behave differently from their free-floating counterparts (planktonic). By producing extracellular signal molecules called autoinducers, the regulation of bacterial gene expression in response to cell population density, called quorum sensing, is accomplished [16] . Biofilm production is regulated in several bacterial pathogens by quorum sensing systems. Biofilms are known to be hard to eradicate and are a source of many chronic infections. Biofilms are medically important, according to the National Institutes of Health, accounting for more than 60% of microbial infections in the body [17] . A mature biofilm can tolerate antibiotics at concentrations of 10-1000 times more than are required to kill planktonic bacteria. Bacteria in biofilms are phagocytosis resistant, making it extremely difficult for biofilms to be eradicated from live hosts [17] . Bacteria in biofilms colonize a wide variety of medical devices, such as catheters, artificial cardiac pacemakers, heart valves and orthopedic devices, and are associated with a number of human diseases, including endocarditis of the valve, burning wound infections, chronic otitis media with effusion and cystic fibrosis [18]. Controls: 20 male and 20 female volunteers who did not have symptoms of any infection. They were selected from outside the hospital environment and were used as controls.
MATERIALS AND METHODS

Study Area
Sample collection: Sterile universal containers containing boric acid preservative were used for urine sample collection while sputum, stool, aspirates and CSF were collected with sterile plain universal bottles. Sterile swabs were used to collect high vaginal, urethral, wound, nasal, ear, anal sample. For blood culture, five milliliters of blood was collected with syringe and put aseptically into fifty milliliters of sterile brain heart infusion (BHI) broth contained in a bijou bottle.
Vancomycin Susceptibility Testing
The vancomycin antibiotic susceptibility patterns of isolates were determined using disk diffusion method as described by CLSI [19] . Reference type E. faecalis strain (ATCC 29212) was used as control.
Other Antibiotic Susceptibility Patterns of Isolates
The isolates were subjected to antibiotic screening by disk diffusion method as described by CLSI [19] . Reference type E. faecalis strain (ATCC 29212) was used as control. The antibiotics used, their classes and disc concentrations were as follows: The interpretative criteria were based on CLSI [19] .
Determination of Multiple Antibiotic Resistance (MAR) Index
The MAR index was determined by dividing the number of antibiotics to which the test isolate was resistant by the total number of antibiotics to which test isolate was evaluated for sensitivity using the formula MAR =X/Y, where X is the number of antibiotics to which test isolates displayed resistance and Y is the total number of antibiotics to which test organism was evaluated for sensitivity.
Plasmid Profile Analysis of Isolates Using 0.8% Agarose Gel Electrophoresis
The plasmid profile analysis of isolates using 0.8% agarose gel electrophoresis was carried out following the method described by DianaRoxana et al. [20] . Fifteen isolates that were highly resistant to antibiotics were selected for plasmid analysis. These were six isolates of E. faecium; five isolates E. faecalis and four isolates of E. avium. The isolates were subjected to bacterial cultures for plasmid profile analysis.
Curing of Plasmid DNA
The curing (elimination) of the resistant plasmids of the enterococci isolated was done using subinhibitory concentration of 0.10 mg/ml of acridine orange as described by Akortha and Filgona [21] . Isolates were grown for 24 hours at 37ºC in Mueller-Hinton broth containing 0.1mg/ml acridine orange. The broth was agitated to homogenize the content and a loopful of the broth medium was cultured on Muller-Hinton agar (MHA) plates and antibiotic sensitivity testing was carried out as previously described. The resistant isolate that became sensitive after curing was regarded as having been cured of the plasmid DNA (plasmid-borne) while the isolate that remained resistant was not cured (chromosomal-borne). Plate 1. Antibiotic susceptibility patterns of Enterococcus sp isolated during this study
The Pathogenicity Factors of the Isolates
These were determined by monitoring virulent determinants such as;
Haemolysin: Haemolysin production by the enterococcal isolates was assessed by a method described by Giridhara et al. [22] .
Gelatinase: Gelatinase production by the enterococcal isolates was assessed by the liquefaction of yeast extract agar containing gelatine plates as described by Giridhara et al. [22] .
Caseinase production: Casein hydrolysis was assessed as described by Archimbaud et al. [23] .
Lipase production: Lipase activity was determined as described by Gunn et al. [24] .
MSCRAMM-Ace:
A drop of distilled water was placed on an end of a slide. A colony of the test organism was emulsified in the drop. A loopful of the patient's serum was added to the suspension and mixed gently. Clumping within 30 seconds indicated a positive reaction [22] .
Detection of β-Lactamase Production
Using sterile forceps, a nitrocef disc (Oxoid Ltd) was removed from the vial and placed on an empty petri dish. Immediately the remaining unused disks were placed into the freezer. Prior to inoculation, the nitrocef disc was allowed to equilibrate to room temperature. Each disc was moistened with one drop of sterile deionized water. The disc was not allowed to over-saturate, which could dilute the reagent. Water is critical to the development of the color reaction, if the disc begins to dry out it may be necessary to rehydrate the reaction area of the nitrocef disc with a small amount of water. With a sterilized loop, a well-isolated colony was removed and spread on the disc surface. The inoculated disc was observed for the development of an orange/red color.
A positive beta-lactamase result was recorded when the nitrocef disc changes color from its original yellow to orange or red. Most positive bacterial strains will produce a color change within 5-60 minutes. A positive beta-lactamase result predicts the following: Resistance to penicillin, ampicillin and amoxicillin as well as acylamino-, carboxy-, and ureido-penicillins. A negative beta-lactamase result was recorded when the Nitrocef Disc remains yellow in color. A negative result did not rule out resistance due to other mechanisms.
Statistical Analysis of Results
The results obtained from this work were analyzed statistically using Chi-square with computer program SPSS version 18 to show significant different.
RESULTS
Susceptibility
Testing, Plasmid Detection and Curing
Summary of precuring antibiogram of the isolates
The 68 isolates of Enterococcus sp. were subjected to antibiotic susceptibility testing before curing using twelve (12) commonly used antibiotics in the study area as shown in Table 1 . 
Antibiotic resistance profile of the three Enterococcus species
Penicillins (β-lactams): All the isolates that make up the three species were resistant to the β-lactam antibiotics used for susceptibility testing. They are 100% resistant to ampicillin and cloxacillin. The pre-curing antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to ampicillin and cloxacillin (Table 2) .
β-lactam-β-lactamase inhibitor combination (Augmentin): Generally, the resistance of the isolates to augmentin was low. 6 (15.3%) of E. faecium were resistant to augmentin; 3 (12.0%) of E. faecalis were resistant to augmentin while 1 (25%) of E. avium was resistant to augmentin. The pre-curing antibiogram of the three Enterococcus species were compared using Chi- (Table 2) .
Macrolides (erythromycin):
Generally, all the isolates were highly resistant to erythromycin 37 (94.9%) of E. faecium were resistant to erythromycin; 23 (92.0%) of E. faecalis were resistant to erythromycin and 3 (75.0%) of E. avium were resistant to erythromycin. The precuring antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to erythromycin (Table 2) .
Fluoroquinolones
Ciprofloxacin: 14 (35%) of E. faecium were resistant to ciprofloxacin, 8 (32%) of E. faecalis were resistant to ciprofloxacin; 2 (50%) of E. avium were resistant to ciprofloxacin. The pre-curing antibiogram of the three Enterococcus species were compared using Chisquare statistics and this revealed that there was no significant difference (p>0.05) in their resistance to ciprofloxacin (Table 2) .
Levofloxacin: 17 (43.6%) of E faecium were resistant to levofloxacin; 5 (20%) of E. faecalis to levofloxcin while 0 (0%) (None) of E. avium was resistant to Levofloxacin. The pre-curing antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to levofloxacin (Table 2) .
Pefloxacin: 15 (38.5%) of E. faecium were resistant to pefloxacin; 7 (28.0%) of E. faecalis were resistant to pefloxacin; 2 (50%) of E. avium were resistant to Pefloxacin. The pre-curing antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to pefloxacin (Table 2) . Table 2 ).
Cephalosporins (cephems)
Cefuroxime: 28 (71.7%) of E. facium were resistant to Cefuroxime, 20 (80.0%) of E .faecalis were resistant to Cefuroxime 2 (50%) of E. avium were resistant to Cefuroxime. The pre-curing antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to Cefuroxime (Table 2) .
Ceftriaxone: 25 (64.1%) of E. faecium were resistant to ceftriaxone; 22 (88.0%) of E. faecalis were resistant to ceftriaxone while 2 (50%) of E. avium were resistant to ceftriaxone. The precuring antibiogram of the three Enterococcus species were compared using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to ceftriaxone (Table 2) .
Pre-curing antibiotic resistance of
nosocomial isolates compared with community acquired isolates β-lactams: (Ampicillin and cloxacillin): 41 (100%) of the nosocomial isolates were resistant to Ampicillin and Cloxacillin while 27 (100%) of the community acquired isolates were resistant to Ampicillin and Cloxacillin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to ampicillin and cloxacillin (Table 3) .
β-lactam-β-lactamase inhibitor combination (Augmentin):
The nosocomial isolates registered low resistance to Augmentin. Only 8 (19.5%) of the nosocomial isolates were resistant to Augmentin. 2 (7%) of the community acquired isolates were resistant to Augmentin. The precuring antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to augmentin (Table 3) .
Glycopeptides (Vancomycin): 15 (36.6%) of the nosocomial isolates were resistant to vancomycinwhile 6 (22%) of the community acquired group were resistant to vancomycin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to vancomycin (Table 3) .
Macrolides (Erythromycin):
41 (100%) of the nosocomial isolates were resistant to Erythromycin while 22 (81.5%) of the community acquired isolates were resistant to Erythromycin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to erythromycin (Table 3) .
Fluoroquinolones
Ciprofloxacin: 16 (39.0%) of the nosocomial isolates were resistant to Ciprofloxacin while 8 (29.6%) of the community acquired group were resistant. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to ciprofloxacin (Table 3) .
Levofloxacin: 17 (41.5%) of the nosocomial group were resistant to levofloxacin while 5 (18.5%) of the community acquired isolated were resistant. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to levofloxacin (Table 3) .
Pefloxacin: 16 (39.0%) of the nosocomial isolates were resistant to pefloxacin while 8 (29.6%) of the acquired isolates were resistant to pefloxacin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to pefloxacin (Table 3) .
Ofloxacin: 20 (48.8%) of the nosocomial isolates were resistant to ofloxacin while 8 (29.6%) of the community acquired isolates were resistant to ofloxacin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to ofloxacin (Table 3) .
Aminoglycosides (Gentamicin): 15 (36.6%) of the nosocomial isolates were resistant to Gentamicin while 10 (37.0%) of the community acquired isolates were resistant to Gentamicin. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to gentamicin (Table  3) .
Cephalosporins
Cefuroxime: 39 (95.1%) of nosocomial isolates were resistant to Cefuroxime while 10 (37.0%) of the community acquired group were resistant to Cefuroxime. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was significant difference (p<0.05) in their resistance to cefuroxime (Table 3) .
Ceftriaxone: 33 (80.5%) of the nosocomial group were resistant to Cefriaxone while 16 (59.3%) of the community acquired group were resistant to Ceftriaxone. The pre-curing antibiogram of nosocomial isolates was compared with community acquired isolates using Chi-square statistics and this revealed that there was no significant difference (p>0.05) in their resistance to ceftriaxone (Table 3) .
Summary of post-curing antibiograms of the isolates
Penicillins (β-Iactams): 58 (85.3%) of the isolates were resistant to ampicillin after curing of the isolates as shown in Table 4 
Pre-curing and post-curing antibiograms of the six plasmid positive enterococal isolates
The pre-curing and post-curing antibiograms of the six plasmid positive isolates were shown on Table 6 . The identification numbers are Pl1, Pl3, Pl4, Pl5, Pl9 and Pl10 with CTL as control. These represent E. faecium, E. faecalis, E. avium, E. faecalis and E. faecalis respectively. The precuring multiple antibiotic resistance (MAR) index for the first isolate Pl1 (E. faecium) was 0.9 while the post-curing MAR index was 0.5. The precuring multiple antibiotic (MAR) index for second isolate (E. faecalis) was 0.7 while the post-curing MAR index was 0.4. Generally the pre-curing MAR index ranged from 0.7 to 0.9 while the postcuring MAR index ranged from 0.4 to 0.6.
DNA plasmid profile of the representative isolates
Six of the 15 representative isolates selected on the basis of their high pre-curing antibiotic resistance for plasmid analysis with 0.8 agarose electrophoresis were positive for plasmid DNA (Table 7) . Four (4) of the positive isolates (E. faecium, E. faecium, E. faecalis, and E. avium) had plasmid fragment of greater than 1000 bp while two (2) of them (E. faecalis and E. faecalis) had fragments of between 100 and 500 bp. The remaining nine (9) had no plasmid DNA. Plate 2 shows five isolates analysed with 0.8% agarose gel electrophoresis. Samples PL1, PL3, PL4 and PL5 were positive for plasmid genes with bands greater than 1000 bp while sample PLl2 was negative.
Plate 3 shows five isolates analysed with 0.8 agarose gel electrophoresis. Samples PL9 and PL10 were positive for plasmid genes with bands between 100 and 500bp while samples PL6, PL7 and PL8 were negative for plasmid genes. Plate 4 shows five isolates analysed with 0.8 % agarose gel electrophoresis. Samples PL11, PL12, PL13, PL19 and PL24 were negative for enterococcal plasmid genes.
Pathogenicity factors: Virulent determinants demonstrated with the enterococcal isolates during the study are displayed on Table 8 .
Haemolysin:
Of the thirty nine (39) E. faecium isolates, twenty six (26) were positive for haemolysin while thirteen (13) were negative. Of the twenty five (25) E. faecalis isolates, seventeen (17) were positive for haemolysin while eight (8) were negative. Of the four (4) E. avium isolates, one (1) was positive while three (3) were negative. In total, 44 (64.7%) of the isolates were positive for haemolysin while 34 (35.3%) were negative. Gelatinase: Of the thirty nine (39) E. faecium isolates, two (2) were positive while thirty seven (37) were negative. The twenty five (25) isolates of E. faecalis were positive for gelatinase. The four (4) E. avium isolates were negative for gelatinase. In total, 27 (39.7%) of the isolates were positive for gelatinase while 41 (60.3%) were negative.
Caseinase: Of the 39 E. faecium isolates, 25 were positive for caseinase while 14 were negative. Of the 25 isolates of E. faecalis, 10 were positive for caseinase while 15 were negative. Of the 4 E. avium isolates, 2 were positive while 2 were negative. In total, 37 (54.4%) of the isolates were positive for caseinase while 31 (45.6%) were negative.
Lipase: Of the 39 E. faecium isolates 20 were positive for lipase while 19 were negative. Of the 25 isolates of E. faecalis, 21 were positive while 4 were negative. Of the 4 E. avium isolates, 1 was positive while 3 were negative. In total, 42 (61.2%) were positive for lipase while 26 (38.8%) were negative.
Microbial surface component recognizing adhesive matrix molecule adhesin of collagen from enterococci MSCRAMM ACE:
Of the thirty nine (39) E. faecium isolates, two (2) were positive for MSCRAMM ACE while thirty seven (37) were negative. Of the twenty five (25) E. faecalis isolates, one (1) was positive while twenty four (24) were negative. Of the four (4) E. avium isolates, one (1) was positive for MSCRAMM ACE while three (3) were negative. In total, 4 (5.9%) of the enterococcal isolates were positive for MSCRAMM-ACE while 64 (94.1%) were negative.
β-lactamase production: β-lactamase enzyme was detected in 19 out of the 39 isolates of E, faecium while 20 were negative. Of the 25 isolates of E. faecalis, 14 were positive for β-lactamase while 11 were negative. Of the 4 isolates of E. avium 2 were positive for β-lactamase while 2 were negative. In total, 35 (51.5%) were positive for β-lactamase production while 33 (48.5%) were negative.
DISCUSSION
Prevalence of Vancomycin Resistant Enterococci
The prevalence of vancomycin resistant Enterococcus (VRE) in this study was 3.3% whereas its percentage among the isolates was 30.9%. This is corroborated by the report of Fisher and Philips [2] that in the last three decades, particularly virulent strains of Enterococcus that were resistant to vancomycin (vancomycin resistant Enterococcus or VRE) have emerged in nosocomial infections of hospitalized patients. The seriousness of this situation will be clearer with the work of Bearman and Winzel, [25] in United Kingdom which demonstrated that the risk of death from vancomycin-resistant enterococci (VRE) is 75%, compared with 45% for those infected with a susceptible strain. This agreed with the work of David et al. [26] who reported resistance to erythromycin to be 73.8% and cloxacillin 84.5%. These findings also agreed with the report of Calva et al. [27] who observed the resistance of enterococci to erythromycin. In summary, the pre-curing antibiogram showed that the isolates were completely resistant to ampicillin and cloxacillin (β-lactams), almost completely resistant to erythromycin (aminoglycoside), cefuroxime and ceftriaxone (cephalosporins). This is in accordance with the report of Ryan and Ray [1] which stated that some enterococci are intrinsically resistant to some β-lactam-based antibiotics (some penicillin and virtually all cephalosporins) as well as many aminoglycosides. β-lactam-β-lactamase inhibitor which was represented by augmentin, exhibited a high level of activity on the isolates. 10 (14.7%) of the isolates were resistant to augmentin while 56 (85.3%) were sensitive to augmentin. 21 (30 
Antibiotic Susceptibility Patterns of the Isolates
Antibiotic Resistant Profile of the Three Enterococcus Species
Penicillins: It is noted that all the three Enterococcus species isolated in this study were resistant to the penicillins evaluated. This has probably got to do with the presence of β-lactamase enzyme in the isolates and other resistance mechanisms. β-lactamase enzyme is an enzyme that breaks the β-lactam ring of the Pencillins (β-Lactams), thus rendering them ineffective against the organisms.
β-lactam-β-lactamase inhibitor combination (augmentin). The isolates in this study were found to register low resistance against augmentin. This is a result of the presence of β-lactamase inhibitor which prevents the β-lactamase produced by the isolates to break the β-lactam ring of the antibiotic.
Vancomycin: E. faecium was found to be averagely resistant to vancomycin (41%). E. faecalis has low resistance (16%) while E. avium also has low resistance (25%). The vancomycin resistance of E. faecalis (16%) and E. avium (25%) was in line with the report of David et al. [26] which recorded a low average vancomycin resistance of 17.4%
Erythromycin: The resistance of the isolates to Erythomycin was marked; E. faecium (94.9%), E. faecalis (92%); E. avium (75%). This is in accordance with the report of David et al. [26] which recorded 73.9% resistance to erythromycin.
Fluoroquinolones
Ciprofloxain: this study showed an average resistance of the isolates to Ciprofloxacin; E. faecium (35%); E. faecalis (32%); E. avium (50%). This is in line with the report of David et al. [26] which recorded 35.6% resistance to ciprofloxacin.
Levofloxacin: E. faecium had an average resistance of 43.6%; E. faecalis had 20% resistance to levofloxacin and isolates of E. avium were not resistant to levofloxacin. Pefloxacin: E. faecium had 38.5% resistance to pefloxacin. E. faecalis had 28% resistance to pefloxacin and E. avium had 50% resistance to pefloxacin.
Ofloxacin:
The resistance of E. faecium to ofloxacin was high (53.8%) but E. faecalis and E. avium registered low resistance 24% and 25% respectively.
Gentamacim:
Resistance to gentamicin by E. faecium was 38.5%. E. faecalis 18% and E. avium 75%.
Cephalosporins:
Cefuroxime: E. faecium and E. faecalis registered high resistance of 71.7% and 80.0% respectively while E. avium registered low resistance of 25% to cefuroxime.
Ceftriaxone: The resistance of the three species to Ceftriaxone was high; E. faecium (64.0%); E. faecalis (88.1%); E. avium (50%). This is in line with the report of Oni et.al. [29] .
Precuring Antibiotic Resistance of Nosocomial Isolates and Community Acquired Isolates
The degree of resistance to some routine antibiotics used in this study by the enterococcal isolates from hospital acquired group was significantly higher than that shown by the community group. Such routine antibiotics include augmentin, levofloxacin, ofloxacin and cefuroxime. Others that showed no significant differences were ampicillin, cloxacillin, vancomycin, erythromycin, ciprofloxacin, pefloxacin, gentamicin and ceftriaxone. However, a high sensitivity of 60% and above was observed in augmentin, vancomycin, ciprofloxacin, levofloxacin peloxacin ofloxacin and gentamicin. The antibiotics sensitivity profile in this study goes a long way to describe the degree of drug abuse and misuse of common routine antibiotics in our society. In addition, continuous exposure of bacteria to routine antibiotics used in the hospital consequently leads to development of resistant strains [29] .
Multiple Antibiotic Resistance (MAR) Index
its cytotoxic and tissue destructive potential and inhibitory effects on phagocytes [10] . Gelatinase production and activity are higher in clinical than faecal isolates from healthy volunteers [11] .
Caseinase: This is extracellular enzyme that catalyzes the hydrolysis of casein, a protein found in milk. Aside supporting the multiplication of the infecting bacteria, caseinase acts as an effective activator of haemolysin which in turn causes the haemolysis of erythrocytes of infected man and other animals [34] .
Twenty five (64.1%) of the thirty nine (39) E. faecium isolates were positive for caseinase while fourteen (35.9%) were negative. Ten (40%) of the twenty five 25 isolates of E. faecalis were positive for caseinase while 15 (60%) were negative. Two (50%) of the four (4) E. avium isolates were positive while two (50%) were negative. Totally, 37 (54.4%) of the isolates were positive for caseinase while 31 (45.6%) were negative.
Lipase: This is an exoenzyme that hydrolyzes the lipid triacylglycerol. The most prominent role of this enzyme is digestion of host extracellular lipids for nutrient acquisition which results in sticking to the host tissue and neighbouring cells [35] . This enhances adhesion by degrading host surface molecules thereby liberating new receptors. Additionally, released free fatty acids (FFA) increases unspecific hydrophobic interactions. The biological role of lipase in infection by many organisms is considered the most important step in bacterial infections [36] .
Twenty (51.3%) of the thirty nine (39) E. faecium isolates were positive for lipase while 19 (48.7%) were negative. Twenty one (84%) of the twenty five (25) isolates of E. faecalis were positive for lipase while 4 (16%) were negative. This agrees with the work of Marcia et al. [37] who demonstrated that 71.8% of E. faecalis presented lipolytic activity. One (25%) of the four (4) E. avium isolates was positive while three (75%) were negative. Totally, 42 (61.2%) were positive for lipase while 26 (38.8%) were negative.
Microbial surface component recognizing adhesive matrix molecule adhesin of collagen from enterococci (MSCRAMM ACE): Ace is a collagen binding MSCRAMM on enterococci and is structurally and functionally related to staphylococcal Cna adhesion [38] . Its presence among both commensal and pathogenic isolates of E. faecalis is apparently expressed during infections in humans [39] . Employing anti Ace antibodies, Ace was detected in 90% of enterococcal endocarditis patients' sera samples suggesting that Ace is expressed in vivo [38] . Two (5.1%) of the thirty nine (39) E. faecium isolates were positive for MSCRAMM ACE while thirty seven (94.9%) were negative. One (4%) of the twenty five (25) E. faecalis isolates was positive while twenty four (96%) were negative. This is not in consonance with the report of Marcia et al. [37] who showed that 40.6% of E. faecalis caused agglutination of rabbit erythrocyte. One (25%) of the four (4) E. avium isolates was positive for MSCRAMM ACE while three (75%) were negative. In total, 4 (5.9%) of the enterococcal isolates were positive for MSCRAMM-ACE while 64 (94.1%) were negative.
β-lactamase production: β-lactamase (also known as penicillinase) is an enzyme produced by some bacteria which has the ability to break the β-lactam ring of β-lactam antibiotics such as penicillins and cephalosporins, deactivating the molecule's antibacterial property. β-lactamase enzyme was detected in 19 out of the 39 isolates of E. faecium while 20 were negative. Of the 25 isolates of E. faecalis, 14 were positive for β-lactamase while 11 were negative. Of the 4 isolates of E. avium 2 were positive for β-lactamase while 2 were negative. In total β-lactamase was detected in 35 (51.5%) of the isolates. This result is not in line with the finding of Rahangdale et al. [40] who reported that strains of enterococci that produce β-lactamase are rare. The implication is that more of the enterococci now produce β-lactamase enzyme which helps them to resist penicillins and cephalosporins.
Development of some mechanisms like inhibition of action of virulence factors and β-lactamase or plasmid curing (removal) may provide an alternate method of therapy in the face of antimicrobial resistance.
CONCLUSION
It was observed that the prevalence of Enterococcus sp. was high and showed multiple drug resistance. It is therefore, advised that more attention should be given to this organism especially VRE.
Adequate antibiotic policy should be articulated and enforced to forestall the emergence of resistant strains and outbreak of the infection. It is recommended that antibiotic sensitivity be obtained before initiation of most antibiotic treatments. The benefits of antibiotic prophylaxis should be thoroughly weighed against the impending resistance to be encountered in the long run. This policy will not only encourage proper treatment of patients but will discourage the indiscriminate use of antibiotics and prevent further development of resistant strains of the bacteria.
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